These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35387811)

  • 1. Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study.
    Wang T; Wang X; Yao Y; Zhao C; Yang C; Han Y; Cai Y
    BMJ Open; 2022 Apr; 12(4):e054347. PubMed ID: 35387811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma BDNF levels with different stages of Alzheimer's disease: a cross-sectional study.
    Wang T; Li T; Hao S; Han Y; Cai Y
    Neurol Res; 2023 Mar; 45(3):234-240. PubMed ID: 36453692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    Chen Y; Lin C; Guo Z; Zhao S; Zhu Y; Huang F; Shui G; Lam SM; Pu J; Yan Y; Liu Z; Zhang B
    J Alzheimers Dis; 2020; 73(2):811-818. PubMed ID: 31868671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
    Hao SW; Li TR; Han C; Han Y; Cai YN
    J Alzheimers Dis; 2023; 92(3):899-909. PubMed ID: 36806511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease.
    Wang T; Yao Y; Han C; Li T; Du W; Xue J; Han Y; Cai Y
    Front Neurol; 2023; 14():1119298. PubMed ID: 37021284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
    Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
    J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    Li Y; Li S; Xu S; Yu H; Tang L; Liu X; Wang X; Zhang Y; Zhang K; Mi S; Chen M; Cui H
    J Alzheimers Dis; 2020; 78(1):277-290. PubMed ID: 32986665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.
    Echevarria-Cooper SL; Ho EH; Gershon RC; Weintraub S; Kahnt T
    Alzheimers Dement; 2024 Jan; 20(1):288-300. PubMed ID: 37603693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 13. Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study.
    Wang HL; Tang R; Ren RJ; Dammer EB; Guo QH; Peng GP; Cui HL; Zhang YM; Wang JT; Xie XY; Huang Q; Li JP; Yan FH; Chen SD; He NY; Wang G
    BMC Med; 2022 Nov; 20(1):380. PubMed ID: 36336678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning-based classification of Alzheimer's disease and its at-risk states using personality traits, anxiety, and depression.
    Waschkies KF; Soch J; Darna M; Richter A; Altenstein S; Beyle A; Brosseron F; Buchholz F; Butryn M; Dobisch L; Ewers M; Fliessbach K; Gabelin T; Glanz W; Goerss D; Gref D; Janowitz D; Kilimann I; Lohse A; Munk MH; Rauchmann BS; Rostamzadeh A; Roy N; Spruth EJ; Dechent P; Heneka MT; Hetzer S; Ramirez A; Scheffler K; Buerger K; Laske C; Perneczky R; Peters O; Priller J; Schneider A; Spottke A; Teipel S; Düzel E; Jessen F; Wiltfang J; Schott BH; Kizilirmak JM
    Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6007. PubMed ID: 37800601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
    Soares HD; Potter WZ; Pickering E; Kuhn M; Immermann FW; Shera DM; Ferm M; Dean RA; Simon AJ; Swenson F; Siuciak JA; Kaplow J; Thambisetty M; Zagouras P; Koroshetz WJ; Wan HI; Trojanowski JQ; Shaw LM;
    Arch Neurol; 2012 Oct; 69(10):1310-7. PubMed ID: 22801723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.
    Dong QY; Li TR; Jiang XY; Wang XN; Han Y; Jiang JH
    Alzheimers Res Ther; 2021 Apr; 13(1):74. PubMed ID: 33827675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.
    Li X; Wang X; Su L; Hu X; Han Y
    BMJ Open; 2019 Jul; 9(7):e028188. PubMed ID: 31350244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers.
    Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y
    Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance and Mobility Performance Along the Alzheimer's Disease Spectrum.
    Yoon B; Choi SH; Jeong JH; Park KW; Kim EJ; Hwang J; Jang JW; Kim HJ; Hong JY; Lee JM; Kang JH; Yoon SJ
    J Alzheimers Dis; 2020; 73(2):633-644. PubMed ID: 31815691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.